Filing Flows › American Healthcare REIT (AHR) › Stock forecast & fair value
American Healthcare REIT (AHR) stock forecast and fair value
American Healthcare REIT (AHR) trades at $57.91. 16 analysts' median price target is $62.50 (+8%), from $55.00 to $74.00. Across 27 valuation methods the middle fair value is $30.46 (-47%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $8.49 | $11.68 | $15.78 | -80% |
| P/E vs peers, weighted | $10.99 | $15.46 | $30.62 | -73% |
| P/E vs peers, matched | $10.83 | $12.99 | $15.18 | -78% |
| EV/EBITDA vs peers | $45.82 | $58.61 | $74.33 | +1% |
| EV/EBITDA vs peers, weighted | $58.73 | $73.79 | $89.45 | +27% |
| EV/EBITDA vs peers, matched | $41.76 | $57.69 | $71.33 | -0.4% |
| EV/Sales vs peers | $50.14 | $108.99 | $141.23 | +88% |
| EV/Sales vs peers, weighted | $108.71 | $145.23 | $172.91 | +151% |
| EV/Sales vs peers, matched | $35.77 | $50.10 | $118.94 | -13% |
| EV/Sales vs peers, growth & margin adjusted | $50.18 | $70.59 | $99.44 | +22% |
American Healthcare REIT's latest quarter
American Healthcare REIT, Q3 2026: revenue $742M (+30% year over year), operating margin 22.2%, net earnings $31.2M, operating cash flow $167M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for AHR stock?
The median of 16 analysts' 12-month targets is $62.50, +8% from $57.91; the range is $55.00 to $74.00. The average rating is strong buy.
What is American Healthcare REIT's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $11.68 and $156.94, with a middle value of $30.46 against a price of $57.91. Each method's assumptions are on the page.
Does American Healthcare REIT usually beat earnings estimates?
It beat the consensus EPS estimate in 40% of the quarters on record.
Is AHR stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.